Parkinson s Disease Foundation. PD ExpertBriefing: Apathy or Depression: Which One Is It?
|
|
- Madlyn Poole
- 6 years ago
- Views:
Transcription
1 Parkinson s Disease Foundation PD ExpertBriefing: Apathy or Depression: Which One Is It? Led By: Dawn Bowers, Ph.D., Professor of Clinical & Health Psychology and Neurology, University of Florida; Director, Cognitive Neuroscience Laboratory at McKnight Brain Institute in Gainesville, FL, and Neuropsychology Director for the UF Center for Movement Disorders and Neurorestoration. This session was held on: Tuesday, June 14, 2016 at 1:00 PM ET. If you have any questions, please contact: Valerie Holt at vholt@pdf.org or call (212)
2 Apathy or Depression Which One Is It? Dawn Bowers, Ph.D., ABPP-CN Professor University of Florida
3 University of Florida J. Robert Cade, Inventor of Gatorade UF Center for Movement Disorders & Neurorestoration
4 UF Center for Movement Disorders and Neurorestoration Our Motivation: Our patients, our parents, our children
5 Plan for Today Explain difference between apathy & depression Discuss why apathy is such a problem in Parkinson s disease the what, why, when & how Explain why some treatments for depression actually worsen apathy Tips for improving apathy
6 Neuropsychiatric Features of Parkinson s Disease Depression Apathy Frightened Anxiety Happy Basal Ganglia Loops Disgusted 20% reducation amygdala volume 30-45% reduction dopamine binding
7 Apathy vs. Depression Depression Apathy THESIS: Depression = Mood disorder Apathy = Motivational disorder signature of PD progression Motivation from the Latin movere, to move
8 What is Apathy? Disorder of motivation Examples of apathetic behavior: Difficulty initiating activity Low activity levels Less interested in trying out or learning new things Lack of effort or reduced productivity Not completing tasks that were started Lack of interest in socializing Not concerned about issues that used to be important Needing someone to remind or prompt
9 Apathy as a Syndrome (Marin, 1991) Cognitive Loss of interest, curiosity Apathy Lack of motivation; Failure to initiate goaldirected behavior Emotion Reduced emotional reactivity, reward Behavioral Reduced initiative; Needs others to structure activities (Marin, 1991) Motivation: To move, activate, energize, from Latin, movere
10 Apathy: Why is it important? In many neurologic diseases (AD, stroke, PD), apathy is associated with: Reduced daily functioning (ADL s & IADL s) Increased caregiver stress/distress Poor illness outcome Poor treatment compliance Worse rehabilitation outcome
11 Average Time Spent in Various Activities by People with Parkinson s with & without Apathy Over a 5 Day Period Apathy Group Not Apathy Group Beata Ferencz, 2009 Master s thesis UF & U. Maastricht
12 Measuring Apathy in PD 1. Apathy Evaluation Scale (AES) 2. Apathy Scale (AS) 3. Lille Apathy Rating Scale (LARS) 4. Apathy subscale from FrSBe 5. Item 7 from Brief Neuropsychiatric Inventory 6. Item 4 from UPDRS MDC Consensus panel, Leentjens et al., 2008), recommend #2 & #6
13 Apathy Scale 14 item scale, modified from Marin Are you interested in learning new things? Does someone have to tell you what to do each day? Are you indifferent to things? 3 Versions: Self- report, clinician rabng, family rabng Reasonable psychometrics Criterion validity - novelty toy task Test- retest Starkstein et al., 1992 Most widely used in PD Ferencz, et al., 2012
14 Lille Apathy Rating Scale (LARS) Sockeel et al., item semi-structured interview tapping 9 domains, items are scored yes-not except 1 st three items; takes 20 minutes to administer 9 DOMAINS 4 Composite Subscales Everyday productivity Interests Taking initiative Novelty seeking Voluntary actions Emotional responses Concern Social life Self-awareness Intellectual Curiosity Emotion Action Initiation (AI) Self-Awareness (SA) TOTAL SCORE -36 (normal) to +36 (abnormal)
15 Assessing Apathy using Item 4 from the UPDRS 0= normal 1= more passive 2= less initiative/disinterest 3= routine events affected 4= withdrawn, total lack Easy, but it lacks right mix of sensitivity/specificity N=301 Idiopathic PD Correlates with AS, but has mediocre ROC, miss too many folks at 0 and 1 Bottom Line: Don t use UPDRS = unified parkinson s disease rating scale Kirsch-Darrow et al., 2009)
16 Our Recommendation 1. Apathy Evaluation Scale (AES) 2. Apathy Scale (AS) 3. Lille Apathy Rating Scale (LARS) 4. Apathy subscale from FrSBe 5. Item 7 from Brief Neuropsychiatric Inventory 6. Item 4 from UPDRS MDC Consensus panel, Leentjens et al., 2008), recommend #2 & #6, also 3
17 Prevalence-Incidence of Apathy in PD Prevalence/incidence depends on how apathy is assessed estimates range from 12% to 70% across studies Tricky, since no formally recognized diagnostic criteria for apathy Recent meta-analysis: almost 40% across 23 studies; apathy associated with lower MMSE, higher UPDRS, older age (den Brok et al. 2015)
18 Proposed Apathy Diagnostic Criteria Starkstein & Leentjens, 2008; adapted from Marin, 1991 A. Lack of motivation relative to previous level of functioning or societal norms B. Presence of at least 1 symptom from each of 3 domains must be present for at least 4 weeks 1. Diminished goal-directed behavior e.g., requires others to structure activity, lack of effort 2. Diminished goal-directed Cognition e.g., lack of interest in new experiences, decreased curiosity 3. Diminished emotion reactivity e.g., emotional blunting, decreased physiological reactivity
19 Proposed Diagnostic Criteria Starkstein & Leentjens, 2008; adapted from Marin, 1991 continued C. Symptoms cause clinically significant distress or impairment in social, occupational, & other areas of functioning D. Symptoms not due to reduced level of consciousness or direct physiological effects of substance (meds, drug abuse, etc.)
20 Depression in PD Depressive Disorders Mood Fluctuations e.g. major depression, dysthymia last from weeks to years can occur at any stage of illness e.g. shifts from dysphoric to euphoric change many times daily occurs mostly in patients who have developed motor fluctuations
21 Diagnosing Depression Clinical interview Depression Scales Self-Rating (Beck; Geriatric Depression Scale) Clinician Ratings (Hamilton, MADRS) DSM-V criteria Structured Clinical Interview (SCID)
22 DiagnosBc Criteria for Major Depression At least 5 of 9 symptoms, including either or both 1 & 2 * * 1. Sad mood 2. Diminished Interest/ Pleasure 3. Weight/appetite loss or gain 4. Insomnia or hypersomnia 5. Slowing or agitation 6. Fatigue/decreased energy 7. Feelings of worthlessness/guilt 8. Indecision/poor concentration 9. Recurring thought of death At least 2 weeks in dura5on, disrup5ve, change
23 Diagnosis of Depression in PD Can Be Difficult Features of PD itself (e.g. bradykinesia, fatigue, insomnia, weight loss, flat affect, concentration problems) can be confused with signs and symptoms of depression Syndromic criteria as outlined by DSM may not apply in PD Currently available depression rating scales were not designed specifically for use in PD
24 Courtesy of H Fernandez
25 Telling Depression & Apathy Apart Unique & Overlapping Symptoms Depression symptoms Sadness Worthlessness Guilt Hopelessness Helplessness Pessimism Suicidal ideation Overlap Anhedonia Less enthusiasm about usual interests Increased slowness Apathy symptoms Decreased initiative Less interest in starting new activities Less interest in world Emotional indifference Decreased emotional reactivity Unique & Overlapping Symptoms in Apathy and Depression Zahodne et al., 2012; Pagonabarraga et al, 2015
26 Why It Is Important to Distinguish Apathy & Depression Relates to treatment Use of SSRI s, common medication for depression, may actually worsen apathy!! Retrospective study at UF, N=181 people with Parkinson s 42% with apathy, 17% with co-occurring depressive symptoms, only 2% had depression only Use of SSRI s, but not other antidepressants associated with increased apathy
27 Apathy in PD: What We Know Distinct from depression Largely dopaminergic related Associated with psychophysiological blunting to emotional pictures (SCR, startle, ERP) Associated with worsening motor symptoms in medically managed PD and worsening cognitive status Associated with older age
28 Neural Systems Underlying Apathy Dopaminergic depletion in brain s motivation circuitry (mesolimbic, D2) Mesolimbic Mesocortical Nigro-striatal Evidence: Worse apathy if taken off dopa meds Especially dopamine (D2) agonists Neuroimaging decreased binding of dopamine in ventral striatum DBS - reduction of dopa-meds results in increased apathy; tx with dopa agonists improves this
29 Apathy is Higher with Greater Disease Severity (Hoehn Yahr) Apathy Scale Score * * Hoehn Yahr Stage Kirsch et al (2006)
30 Apathy Worsens with Motor Disease Progression N=186 idiopathic PD; Tested over 18 month period Motor Score Apathy Depression Zahodne et al., 2011
31 Apathy & Depression in PD Relationship to Cognitive Status 100 Percentage of Patients who were apathetic or depressed % of Ss % 36% 80% 24% 26% 48% Not Demented N=111 Unknown N=80 Demented N=35 0 Apathy Depression AS & BDI-II cutoffs Kellison et al., 2007
32 Predicting Apathy in Non-demented People with Parkinson s N-111 nondemented people with Parkinson s Apathy Scale (AS) Stroop Interference, Age, & BDI-II Kirsch-Darrow, 2009
33 Differential Influence of Apathy & Depression on Cognition Behavior Emotion Psychophysiology
34 Behavior: Novelty Toy Task Ferencz et al (2012) Lab based task of exploration 100 % Time Playing with Toys % time (10 min) % * 81% 0 Ferencz, et al., 2012 Apathy Nonapathy GROUP
35 Emotion Reactivity Psychophysiology blunting Skin conductance, startle Hypoarousal Electrophysiology blunting Reduced ERP to emotion pix Reduced novelty detection (P300) Bowers et al., 2006; Miller et al., 2009, Dietz et al, 2015; Kaufman et al., 2016
36 To Recap Apathy common in PD, disbnct from depression Occurs in both demented and non- demented PD Best cognibve predictors of apathy in non- demented PD are frontal tasks such as the Stroop Associated with physiologic blunbng to emobonal pictures Related to disease severity and age. Implication Apathy is an intrinsic part of Parkinson s disease
37 Apathy in PD: What we don t know Is apathy merely a signature for disease progression? How to best treat apathy? What are the best approaches for bolstering motivation and drive? Pharmacologic Nonpharmacologic
38 Apathy Treatment Adcock et al, Neuron, 2016 Pix from KQED News, NPR
39 Apathy Treatment Pharmacologic No silver bullet Nonpharmacologic Stimulation (rtms) Behavioral approaches
40 Pharmacologic Relatively few randomized clinical trials these are gold standard Most studies involve increasing some variant of dopamine Only a few have made apathy the main focus; for most, apathy is secondary 1. Dopamine agonists Pramipexole vs. Ropinirole (Julez et al., 2015)* Piribedil (D2-D3) Rotigotine (aka Neupro ) 2. Methylphenidate 3. Rivastigmine (Exelon patch)- (Devos et al, 2014)* (cholinergic nondemented PD)
41 The Restore Study (rtms) Brain Stimulation repetitive Transcranial Magnetic Stimulation To learn whether rtms would improve apathy in people with Parkinson s PD participants with apathy randomly assigned to rtms or to Sham condition; Tx = 2 weeks Sham rtms Apathetic PD N=24 Real rtms Primary outcome: Apathy Scale Score Fernandez, Bowers et al.
42 The Restore Study (rtms) Brain Stimulation repetitive Transcranial Magnetic Stimulation Results: Terrific! Apathy Improved Apathetic PD N=24 Sham rtms Real rtms Dramatic improvement in apathy, as measured by AS and LARS But true for both groups WHY? Fernandez, Bowers et al. Behavioral Activation? Placebo?
43 Behavioral Approaches for Improving Apathy 1. Dance Therapy 2. Music Therapy 3. Exercise 4. Cognitive Training 5. Behavioral Activation - PAL program
44 Cognitive Training Studies in normal aging (ACTIVE TRIAL; VITAL) and mild cognitive impairment; improvements and generalization Changes in dopamine D1 receptors following working memory training (Klingberg et al., 2009) Tasks: computer based programs; video games, crossword puzzles, bingo, cards, etc. Parkinson s Disease: Several studies in Parkinson s disease. Improvement in processing speed; trends for apathy. (Pena et al., 2014)
45 Parkinson s Active Living (PAL) Butterfield et al., in press Behavioral Activation & Goal Setting program developed specifically for Parkinson s disease Targeted outcome = apathy 6 weeks, telehealth Key Elements Identified 5 goals during initial in-person session 2 for Week 1, 3 for Wk 2, 4 for Wk 3, all 5 for remaining Weeks Developed specific plans & schedules Weekly telehealth session with program coach I-Ping reminders
46 Parkinson s Active Living (PAL) Butterfield et al., in press This was single arm unblinded study Goals was this feasible & acceptable? would this approach improve apathy? Results: Feasibility: 4 of 32 dropped out (12% attrition) Acceptability: satisfaction 87.5 on 100 scale Apathy significantly improved: AES QOL significantly improved No changes in caregiver burden/stress
47 Getting Motivated - Best Practices Goal Setting - cornerstone of motivation Specific Attainable (realistic) Not too easy Commitment - self-set goals best Positive feedback - a reward Implementation Specific plans when, where, how Prepare for potential setbacks External Cues Reminders, schedule
48 Other Tips for Motivation Be SMART in selecting goals S - specific goals M - measurable A - attainable R - realistic T - timely From Butterfield et al, in press
49 Other Tips for Behavioral UF Brain Activity Guide Outings Crafts & Hobbies Music Nature In the Home Verbal Skills Games Reminiscing Activation
50 Bottom Line Apathy is a motivational disorder whereas Depression is a mood disorder Tip: Sadness, guilt, worrisomeness, hopelessness all point to depression. Not apathy. Tip: Decreased initiation, loss of get up and go may point to apathy. Apathy worsens with disease progression and is associated with dopaminergic depletion in the brain s motivational circuits. It has impact on daily activities, treatment outcomes and caregiver distress.
51 Bottom Line Treatment approaches are pharmacologic and behavioral Tip: Make sure patient is on optimal doses of dopa medications, particularly dopamine agonists (if possible) Tip: Avoid SSRI s if possible Tip: KEEP MOVING; Use some variant of behavioral activation and goal setting! Even if patient cannot do own goal setting, keeping active (behavioral activation) is critical There is great individual variability what is not variable is to keep moving
52 Thank You! I am happy to take questions Thank you to my funding sources at the NIH, Michael J. Fox Foundation, the National Parkinson Foundation, and the state of Florida. Thank you to the staff at the Parkinson s Disease Foundation For updates, go to
53 Thank You! My Parkinson s diagnosis in 2008 may have closed the door on my piloting career, but it opened a new one to the world of woodworking. Through my craft, I have not only found a way to retain my fine motor skills, I have also regained my purpose. Carousel Studio, Bart Kadleck PDF Creativity and Parkinson s Project 53
54 Questions and Discussion 54
55 Resources from PDF Fact Sheets CombaBng Depression Online Seminars A Closer Look at Anxiety and Depression in Parkinson's Disease Under- recognized Nonmotor Symptoms of Parkinson's Disease Parkinson s HelpLine Available at (800) or info@pdf.org Monday through Friday 9:00 AM 5:00 PM ET 55
Parkinson s Disease Foundation. PD ExpertBriefing: Anxiety in Parkinson s Disease
Parkinson s Disease Foundation PD ExpertBriefing: Anxiety in Parkinson s Disease Led By: Joseph H. Friedman, M.D., Director of the Movement Disorders Program of Butler Hospital and Professor and Division
More informationDEPRESSION AFTER STROKE
DEPRESSION AFTER STROKE Research study results and practical suggestions Julie Kidd 1 November 2018 Outline Definition Diagnosis Associations Prevention Treatment Outcomes From a person with stroke Emphasises
More informationAnxiety and Depression Are Better Correlates of Parkinson s Disease Quality of Life Than Apathy
This article addresses the Core Competency of Patient Care and Procedural Skills ARTICLES Anxiety and Depression Are Better Correlates of Parkinson s Disease Quality of Life Than Apathy Jacob D. Jones,
More informationWHY FOCUS ON APATHY? DIAGNOSIS, SYMPTOMS ASSESSMENT, METHODOLOGY FRAMEWORK. David S. Miller, MD, MA 2 September 2017 ISCTM
WHY FOCUS ON APATHY? DIAGNOSIS, SYMPTOMS ASSESSMENT, METHODOLOGY FRAMEWORK David S. Miller, MD, MA 2 September 2017 ISCTM ALTERNATE TITLE: WHO'LL STOP THE TRAIN? David S. Miller, MD, MA 2 September 2017
More informationEDITORS PICK CLINICAL SIGNIFICANCE OF APATHY IN PARKINSON S DISEASE. Kinan Muhammed, *Masud Husain
EDITORS PICK The significant health burden that apathy creates for patients with Parkinson s disease is revealed in the following article by Muhammed and Husain; also highlighted are the difficulties of
More informationParkinson s Disease Foundation. PD ExpertBriefing: Managing the Motor Symptoms in PD
Parkinson s Disease Foundation PD ExpertBriefing: Managing the Motor Symptoms in PD Led By: Sotirios A. Parashos, M.D. Minneapolis Clinic of Neurology and Struthers Parkinson's Center This session was
More informationBehavioral Aspects of Parkinson s Disease
Behavioral Aspects of Parkinson s Disease Joseph H. Friedman, MD Director, Movement Disorders Program Butler Hospital Dept of Neurology Alpert Medical School of Brown University 1 Disclosures Drugs will
More informationA pathy refers to a set of behavioural, emotional, and
579 PAPER The Lille apathy rating scale (LARS), a new instrument for detecting and quantifying apathy: validation in Parkinson s disease P Sockeel, K Dujardin, D Devos, C Denève, A Destée, L Defebvre...
More informationPD ExpertBriefing: The Effects of Exercise on PD
PD ExpertBriefing: The Effects of Exercise on PD Led By: Margaret Schenkman, P.T., Ph.D., F.A.P.T.A. Associate Dean for Physical Therapy Education, and Director, Physical Therapy Program, University of
More informationIs Apathy a Valid and Meaningful Symptom or Syndrome in Parkinson s Disease? A Critical Review
Health Psychology 2011 American Psychological Association 2011, Vol. 30, No. 4, 386 400 0278-6133/11/$12.00 DOI: 10.1037/a0022851 Is Apathy a Valid and Meaningful Symptom or Syndrome in Parkinson s Disease?
More informationA correlational study of apathy and depression in Parkinson's Disease
The University of Toledo The University of Toledo Digital Repository Master s and Doctoral Projects A correlational study of apathy and depression in Parkinson's Disease Julia L. Hill The University of
More informationPost-Stroke Depression (PSD) NIH StrokeNet Grand Rounds, April 26, 2018 Pamela H. Mitchell, PhD, RN, FAAN, FAHA
Post-Stroke Depression (PSD) NIH StrokeNet Grand Rounds, April 26, 2018 Pamela H. Mitchell, PhD, RN, FAAN, FAHA Objectives Describe the scope of the problem of depression and stroke Evaluate the evidence
More informationCognitive Impairment - Parkinson's Disease Foundation (PDF)
Page 1 of 8 Cognitive Impairment Another troublesome symptom of Parkinson s is mild cognitive impairment. Many people with Parkinson s are surprised to find that they feel distracted or disorganized, or
More information9/24/2012. Amer M Burhan, MBChB, FRCP(C)
Depression and Dementia Amer M Burhan MBChB, FRCPC Head of CAMH Memory Clinic, Toronto Geriatric Neuropsychiatrist Assistant Prof Psychiatry at U of T Objectives Discuss the prevalence and impact of depression
More informationNadina Lincoln University of Nottingham
Nadina Lincoln University of Nottingham Screening for emotional distress How do we screen? Prevention of distress Detect distress Distress impedes progress Refer for further evaluation Consider for intervention
More informationDepression and Anxiety in Parkinson s Disease. Bill Collins Symposium for Parkinson s Disease 2018 Robert Underwood, Ph.D. Licensed Psychologist
Depression and Anxiety in Parkinson s Disease Bill Collins Symposium for Parkinson s Disease 2018 Robert Underwood, Ph.D. Licensed Psychologist Today s Discussion Review of Parkinson s Disease and Nonmotor
More informationNumber of Items. Response Categories. Part V: Specific Behavior Scales-Sleep Scales. Based on past month
Part V: Specific Behavior Scales-Sleep Scales Based on past month First 4 items ask for time or amount of sleep 41. Pittsburgh Sleep Quality Index (PSQI) Sleep quality Sleep latency Sleep duration Habitual
More informationThe PD You Don t See: Cognitive Symptoms. Joanne M. Hamilton, PhD, ABPP Clinical Neuropsychologist Division of Neurology Scripps Health
The PD You Don t See: Cognitive Symptoms Joanne M. Hamilton, PhD, ABPP Clinical Neuropsychologist Division of Neurology Scripps Health OBJECTIVES To understand why cognitive changes occur in a motor disease
More informationThe Effect of Pramipexole on Depressive Symptoms in Parkinson's Disease.
Kobe J. Med. Sci., Vol. 56, No. 5, pp. E214-E219, 2010 The Effect of Pramipexole on Depressive Symptoms in Parkinson's Disease. NAOKO YASUI 1, KENJI SEKIGUCHI 1, HIROTOSHI HAMAGUCHI 1, and FUMIO KANDA
More informationManaging Challenging Behaviors
Managing Challenging Behaviors Barbara J. Kocsis, MD Psychiatry Resident, HDSA Center of Excellence UC Davis School of Medicine & Lorin M. Scher, MD Attending Psychiatrist, HDSA Center of Excellence UC
More informationArticle. Reference. Apathy in Parkinson's disease: clinical features, neural substrates, diagnosis, and treatment. PAGONABARRAGA, Javier, et al.
Article Apathy in Parkinson's disease: clinical features, neural substrates, diagnosis, and treatment PAGONABARRAGA, Javier, et al. Reference PAGONABARRAGA, Javier, et al. Apathy in Parkinson's disease:
More informationMood Disorders Workshop Dr Andrew Howie / Dr Tony Fernando Psychological Medicine Faculty of Medical and Health Sciences University of Auckland
Mood Disorders Workshop 2010 Dr Andrew Howie / Dr Tony Fernando Psychological Medicine Faculty of Medical and Health Sciences University of Auckland Goals To learn about the clinical presentation of mood
More informationThe validity of the hospital anxiety and depression scale and the geriatric depression scale in Parkinson s disease
Behavioural Neurology 17 (2006) 109 115 109 IOS Press The validity of the hospital anxiety and depression scale and the geriatric depression scale in Parkinson s disease Federica Mondolo a,, Marjan Jahanshahi
More informationDepression and RLS. John W. Winkelman MD, PhD Departments of Psychiatry and Neurology Massachusetts General Hospital
Depression and RLS John W. Winkelman MD, PhD Departments of Psychiatry and Neurology Massachusetts General Hospital Associate Professor of Psychiatry Harvard Medical School A 42 year old man has a three
More informationParkinson s Disease Foundation. Parkinson s Disease Foundation. PD ExpertBriefing: Led By: Ronald F. Pfeiffer, M.D. To hear the session live on:
Parkinson s Disease Foundation Parkinson s Disease Foundation PD ExpertBriefing: Gait, Balance PD and ExpertBriefing: Falls in Parkinson s Disease Understanding Led By: the Terry Progression Ellis, Ph.D.,
More informationOptimizing Clinical Communication in Parkinson s Disease:
Optimizing Clinical Communication in Parkinson s Disease:,Strategies for improving communication between you and your neurologist PFNCA Symposium March 25, 2017 Pritha Ghosh, MD Assistant Professor of
More informationMarch 29, 2017 Debra K. Smith, Ph.D. St. Charles Hospital Port Jefferson, New York
Traumatic Brain Injury: Management of Psychological and Behavioral Sequelae March 29, 2017 Debra K. Smith, Ph.D. St. Charles Hospital Port Jefferson, New York The Functional Impact of
More informationHDSA Annual Convention June 2013 Behavior Issues: Irritability and Depression Peg Nopoulos, M.D.
HDSA Annual Convention June 2013 Behavior Issues: Irritability and Depression Peg Nopoulos, M.D. Professor of Psychiatry, Neurology, and Pediatrics University of Iowa, Iowa City, Iowa The information provided
More informationALLIED TEAM TRAINING FOR PARKINSON
ALLIED TEAM TRAINING FOR PARKINSON PSYCHOSOCIAL CHALLENGES IN EARLY STAGE PD Elaine Book, M.S.W. 1 Learning Objectives Examine the role of social work in the provision of psycho-social treatment for individuals
More informationAnticholinergics. COMT* Inhibitors. Dopaminergic Agents. Dopamine Agonists. Combination Product
Drug Use Research & Management Program Oregon State University, 500 Summer Street NE, E35, Salem, Oregon 97301-1079 Phone 503-945-5220 Fax 503-947-1119 Class Update: Parkinson s Drugs Month/Year of Review:
More informationBuy full version here - for $ 5.00
This is a Sample version of the Apathy Inventory (AI) The full version of watermark.. the AI comes without sample The full complete 13 page version includes AI Overview information AI Scoring/ Administration
More informationRecognizing and Managing the Emotional Aspects of Parkinson s. Pamela R. Palmentera, LCSW Coordinator & Clinical Social Worker
Recognizing and Managing the Emotional Aspects of Parkinson s Pamela R. Palmentera, LCSW Coordinator & Clinical Social Worker Sensory information from the one hemisphere crosses over to the other side
More informationDeep brain stimulation (DBS) has been
TOPIC RESEARCH HUMAN CLINICAL STUDIES RESEARCH HUMAN CLINICAL STUDIES Do Stable Patients With a Premorbid Depression History Have a Worse Outcome After Deep Brain Stimulation for Parkinson Disease? Michael
More informationClinical applications of real-time fmri neurofeedback in 6 steps
Training course: Real-time fmri: Fundamental Principles for Clinical Applications Clinical applications of real-time fmri neurofeedback in 6 steps David Linden Cardiff University 1) What is your clinical
More informationManaging Challenging Behaviors
Managing Challenging Behaviors Barbara J. Kocsis, MD Psychiatry Resident, HDSA Center of Excellence UC Davis School of Medicine In partnership with Drs. Lorin Scher, MD and Vicki Wheelock, MD 1 Our Goal
More informationProgram Highlights. Michael Pourfar, MD Co-Director, Center for Neuromodulation New York University Langone Medical Center New York, New York
Program Highlights David Swope, MD Associate Professor of Neurology Mount Sinai Health System New York, New York Michael Pourfar, MD Co-Director, Center for Neuromodulation New York University Langone
More informationClinical Trial Results Posting
RD..3.2 V1. Page/Seite 1 of/von 5 CT Registry ID#: NCT2428 (ClinicalTrials.gov Identifier number) These results are supplied for informational purposes only. Prescribing decisions should be made based
More informationCouncil on Chemical Abuse Annual Conference November 2, The Science of Addiction: Rewiring the Brain
Council on Chemical Abuse Annual Conference November 2, 2017 The Science of Addiction: Rewiring the Brain David Reyher, MSW, CAADC Behavioral Health Program Director Alvernia University Defining Addiction
More information10th Medicine Review Course st July Prakash Kumar
10th Medicine Review Course 2018 21 st July 2018 Drug Therapy for Parkinson's disease Prakash Kumar National Neuroscience Institute Singapore General Hospital Sengkang General Hospital Singhealth Duke-NUS
More informationCaregiving for an Individual with Dementia: Beginning the Journey
Caregiving for an Individual with Dementia: Beginning the Journey Kirsten W. Schwehm, PhD, ABN Institute for Dementia Research and Prevention Getting the Diagnosis Physician Assessment Cognitive Assessment
More informationBenefits of exercise Fatigue Types of exercise Overview Considerations following Brain Tumour How does the brain affect movement How does the brain co
Exercise following Brain Tumour Presenter: Sally Humphrey Senior Physiotherapist Neurology / Neurosurgery RNSH Benefits of exercise Fatigue Types of exercise Overview Considerations following Brain Tumour
More informationTIP 48 MANAGING DEPRESSIVE SYMPTOMS IN SUBSTANCE ABUSE CLIENTS DURING EARLY RECOVERY
MANAGING DEPRESSIVE SYMPTOMS IN SUBSTANCE ABUSE CLIENTS DURING EARLY RECOVERY Presented by: William L. Mock, Ph.D., LISW,LICDC, SAP Professional Training Associates Inc North Ridgeville, Ohio 1 (216) 299-9506
More informationPD ExpertBriefing: Impulsive and Compulsive Behaviors in Parkinson s Disease
PD ExpertBriefing: Impulsive and Compulsive Behaviors in Parkinson s Disease Presented By: Daniel Weintraub, M.D. Associate Professor of Psychiatry, University of Pennsylvania; Parkinson s Disease and
More informationA Validation Study of Depressive Syndromes in Parkinson s Disease
Movement Disorders Vol. 23, No. 4, 2008, pp. 538-546 2007 Movement Disorder Society A Validation Study of Depressive Syndromes in Parkinson s Disease Sergio E. Starkstein, MD, PhD, 1,2 * Marcelo Merello,
More informationReview of Various Instruments Used with an Adolescent Population. Michael J. Lambert
Review of Various Instruments Used with an Adolescent Population Michael J. Lambert Population. This analysis will focus on a population of adolescent youth between the ages of 11 and 20 years old. This
More informationAddressing Difficult Behaviors in Dementia
Addressing Difficult Behaviors in Dementia GEORGE SCHOEPHOERSTER, MD GERIATRICIAN GENEVIVE/CENTRACARE CLINIC Objectives By the end of the session, you will be able to: 1) Explain the role of pain management
More informationPsychiatric and Behavioral Challenges in HD
Psychiatric and Behavioral Challenges in HD Lorin M. Scher, MD Department of Psychiatry and Behavioral Sciences UC Davis School of Medicine June 8 th 2012 1 Disclosure Advisory Board for Lundbeck Inc.
More informationDistinct effects of apathy and dopamine on effort-based decision-making in Parkinson s disease
doi:10.1093/brain/awy110 BRAIN 2018: 141; 1455 1469 1455 Distinct effects of apathy and dopamine on effort-based decision-making in Parkinson s disease Campbell Le Heron, 1,2,3 Olivia Plant, 2 Sanjay Manohar,
More information5/12/11. Educational Objectives. Goals
Educational Objectives Learn: steps for initial depression screening and management in primary care when to refer to mental health providers tools for providers and patients principles of collaborative
More informationAre All Older Adults Depressed? Common Mental Health Disorders in Older Adults
Are All Older Adults Depressed? Common Mental Health Disorders in Older Adults Cherie Simpson, PhD, APRN, CNS-BC Myth vs Fact All old people get depressed. Depression in late life is more enduring and
More informationBuy full version here - for $ 7.00
This is a Sample version of the Apathy Evaluation Scale (AES) The full version of watermark.. the AES comes without sample The full complete 40 page version includes AES Overview information AES Scoring/
More informationDEMENTIA and BPSD in PARKINSON'S DISEASE. DR. T. JOHNSON. NOVEMBER 2017.
DEMENTIA and BPSD in PARKINSON'S DISEASE. DR. T. JOHNSON. NOVEMBER 2017. Introduction. Parkinson's disease (PD) has been considered largely as a motor disorder. It has been increasingly recognized that
More informationdepression and anxiety in later life clinical challenges and creative research
2 nd Annual MARC Symposium Critical Themes in Ageing Melbourne, 10 th August 2018 depression and anxiety in later life clinical challenges and creative research Nicola T Lautenschlager, MD, FRANZCP Professor
More informationNeurogenic Disorders: Assessing/Managing Patient Motivation
Neurogenic Disorders: Assessing/Managing Patient Motivation Michael Biel, CScD, CCC-SLP 1 Motivation 1 Disorders of diminished motivation 2 Motivation and Rehabilitation Assessment Management 3 4 5 2 Most
More informationMajor Depressive Disorder Websites Reviewed by Felisha Lotspeich
Major Depressive Disorder Websites Reviewed by Felisha Lotspeich Major depression. (2010). https://health.google.com/health/ref/major+depression This Website gives basic information about major depressive
More informationSensitivity and specificity of depression screening tools among adults with intellectual and developmental disabilities (I/DD)
Sensitivity and specificity of depression screening tools among adults with intellectual and developmental disabilities (I/DD) Sarah H Ailey PhD RNC Rush University College of Nursing College of Nursing
More informationPsychiatric aspects of Parkinson s disease an update
Psychiatric aspects of Parkinson s disease an update Dr Chris Collins 027 2787593 chris.collins@cdhb.health.nz Disclosures: none Non-motor aspects physical Sensory anosmia, visual symptoms Speech and
More informationSymptoms Duration Impact on functioning
Dr. Lori Triano- Antidormi Dr. Jane Storrie OPA Annual Conference February 21, 2015 Symptoms Duration Impact on functioning Numbness, shock, disbelief, denial Sadness Apathy, lack of interest, enthusiasm
More informationNeuropsychology and Parkinson s Disease. Erin Holker, Ph.D., ABPP Neuropsychology Laboratory
Neuropsychology and Parkinson s Disease Erin Holker, Ph.D., ABPP Neuropsychology Laboratory Parkinson s disease and cognition Parkinson s disease is not just a disorder of movement The same circuits associated
More informationParkinson s Foundation
Parkinson s Foundation PD ExpertBriefing: Diagnosis PD, Now What? Managing the First Few Years with Parkinson s Led By: Suketu Khandhar, M.D., Medical Director at Kaiser Permanente Northern California
More informationDEPRESSION, WHAT CAN YOU DO ABOUT IT?
DEPRESSION, WHAT CAN YOU DO ABOUT IT? by Patricia Gavotto, Psychologist Port Vila 77 46321 100 milliards de neurones About 10% of men and 25% of women will experience depression in their lifetime. Depression
More informationDementia. Assessing Brain Damage. Mental Status Examination
Dementia Assessing Brain Damage Mental status examination Information about current behavior and thought including orientation to reality, memory, and ability to follow instructions Neuropsychological
More informationWEBINAR SERIES: AGING IN INDIVIDUALS WITH INTELLECTUAL AND DEVELOPMENTAL DISABILITIES
WEBINAR SERIES: AGING IN INDIVIDUALS WITH INTELLECTUAL AND DEVELOPMENTAL DISABILITIES 1 CMS Medicare-Medicaid Coordination Office (MMCO) Established by Section 2602 of the Affordable Care Act Purpose:
More informationPharmacological Treatments for Neuropsychiatric Symptoms in Dementia 3/22/2018
Pharmacological Treatments for Neuropsychiatric Symptoms in Dementia 3/22/2018 Mary Ellen Quiceno, MD, FAAN Associate Professor of Neurology UNTHSC Center for Geriatrics 855 Montgomery Street, PCC 4, Ft.
More informationMedical Inference: Using Explanatory Coherence to Model Mental Health Assessment and Epidemiological Reasoning Paul Thagard paulthagard.
Medical Inference: Using Explanatory Coherence to Model Mental Health Assessment and Epidemiological Reasoning Paul Thagard paulthagard.com 1 Outline 1. Computer modeling 2. Mental health assessment 3.
More informationThe Frontal Lobes. Anatomy of the Frontal Lobes. Anatomy of the Frontal Lobes 3/2/2011. Portrait: Losing Frontal-Lobe Functions. Readings: KW Ch.
The Frontal Lobes Readings: KW Ch. 16 Portrait: Losing Frontal-Lobe Functions E.L. Highly organized college professor Became disorganized, showed little emotion, and began to miss deadlines Scores on intelligence
More informationOverview. Case #1 4/20/2012. Neuropsychological assessment of older adults: what, when and why?
Neuropsychological assessment of older adults: what, when and why? Benjamin Mast, Ph.D. Associate Professor & Vice Chair, Psychological & Brain Sciences Associate Clinical Professor, Family & Geriatric
More informationTHE BEHAVIOURAL VITAL SIGNS (BVS) TOOL
DID YOU KNOW THE BEHAVIOURAL VITAL SIGNS (BVS) TOOL. Did you know that it is essential to know the target cluster(s)/symptom(s) one is treating to guide and monitor non-pharmacological approaches and pharmacological
More informationCoach on Call. Please give me a call if you have more questions about this or other topics.
Coach on Call It was great to talk with you. Thank you for your interest in. I hope you find this tip sheet helpful. Please give me a call if you have more questions about this or other topics. As your
More informationRepetitive transcranial magnetic stimulation for depression
NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE Interventional procedure consultation document Repetitive transcranial magnetic stimulation for depression Depression causes low mood or sadness that can
More informationAN OVERVIEW OF ANXIETY
AN OVERVIEW OF ANXIETY Fear and anxiety are a normal part of life. Normal anxiety keeps us alert. Intervention is required when fear and anxiety becomes overwhelming intruding on a persons quality of life.
More informationThe ABCs of Dementia Diagnosis
The ABCs of Dementia Diagnosis Dr. Robin Heinrichs, Ph.D., ABPP Board Certified Clinical Neuropsychologist Associate Professor, Psychiatry & Behavioral Sciences Director of Neuropsychology Training What
More informationInformation for patients, families and caregivers
Depression Information for patients, families and caregivers Read this booklet to learn: what depression is what causes it the signs or symptoms of depression what treatments can help Please visit the
More informationCRITICALLY APPRAISED PAPER (CAP)
CRITICALLY APPRAISED PAPER (CAP) FOCUSED QUESTION Does the Tailored Activity Program (TAP) for dementia patients reduce caregiver burden and neuropsychiatric behavior compared to a wait-list control group
More informationDr. Catherine Mancini and Laura Mishko
Dr. Catherine Mancini and Laura Mishko Interviewing Depression, with case study Screening When it needs treatment Anxiety, with case study Screening When it needs treatment Observation Asking questions
More informationEvaluation and Management of Parkinson s Disease in the Older Patient
Evaluation and Management of Parkinson s Disease in the Older Patient David A. Hinkle, MD, PhD Comprehensive Movement Disorders Clinic Pittsburgh Institute for Neurodegenerative Diseases University of
More informationAnnouncements. Grade Query Tool+ PsychPortal. Final Exam Wed May 9, 1-3 pm
Grade Query Tool+ Announcements This tool is the definitive source for your final grade! Now includes Grade Estimator Tool PsychPortal Technical glitches in Learning Curves for Chapters 5, 14, and 15 are
More informationASHI691: Why We Fall Apart: The Neuroscience and Neurophysiology of Aging. Dr. Olav E. Krigolson Lecture 5: PARKINSONS DISEASE
ASHI691: Why We Fall Apart: The Neuroscience and Neurophysiology of Aging Dr. Olav E. Krigolson krigolson@uvic.ca Lecture 5: PARKINSONS DISEASE The Basal Ganglia Primary motor cortex Execution of movement
More informationIntegrated Care for Depression, Anxiety and PTSD. Introduction: Overview of Clinical Roles and Ideas
Integrated Care for Depression, Anxiety and PTSD University of Washington An Evidence-based d Approach for Behavioral Health Professionals (LCSWs, MFTs, and RNs) Alameda Health Consortium November 15-16,
More informationEmotional dysfunction in Parkinson s disease
Behavioural Neurology 24 (2011) 201 217 201 DOI 10.3233/BEN-2011-0329 IOS Press Emotional dysfunction in Parkinson s disease Lee X. Blonder a, and John T. Slevin b a Sanders-Brown Center on Aging and Departments
More informationApathy, fatigue and quality of life in patients with Parkinson's disease Skorvanek, Matej
University of Groningen Apathy, fatigue and quality of life in patients with Parkinson's disease Skorvanek, Matej IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's PDF) if
More informationIan McKeith MD, F Med Sci, Professor of Old Age Psychiatry, Newcastle University
Ian McKeith MD, F Med Sci, Professor of Old Age Psychiatry, Newcastle University Design of trials in DLB and PDD What has been learnt from previous trials in these indications and other dementias? Overview
More informationCognitive-Motor Interference in Persons with Parkinson Disease
Cognitive-Motor Interference in Persons with Parkinson Disease Tara L. McIsaac, PhD, PT Associate Professor of Physical Therapy A.T. Still University Arizona School of Health Sciences October 11, 2014
More informationPsychosocial Problems In Reproductive Health Of Elders
Psychosocial Problems In Reproductive Health Of Elders Dr. Sonia Oveisi Maternity and Child Health Assistant Professor of Qazvin University of Medical Science 6/2/2014 1 Goals 1. Definition 2. Epidemiology
More informationDepression in the Eldery Handout Package
Depression in the Eldery Handout Package Depression in the Elderly 1 Learning Objectives Upon completion of this module, you should be able to: 1. State the prevalence and describe the consequences of
More informationDepression Fact Sheet
Depression Fact Sheet Please feel free to alter and use this fact sheet to spread awareness of depression, its causes and symptoms, and what can be done. What is Depression? Depression is an illness that
More informationMeasure #106 (NQF 0103): Adult Major Depressive Disorder (MDD): Comprehensive Depression Evaluation: Diagnosis and Severity
Measure #106 (NQF 0103): Adult Major Depressive Disorder (MDD): Comprehensive Depression Evaluation: Diagnosis and Severity 2014 PQRS OPTIONS FOR INDIVIDUAL MEASURES: CLAIMS, REGISTRY DESCRIPTION: Percentage
More informationDepression in Late Life
Depression in Late Life Robert Madan MD FRCPC Geriatric Psychiatrist Key Learnings Robert Madan MD FRCPC Key Learnings By the end of the session, participants will be able to List the symptoms of depression
More informationUnited Council for Neurologic Subspecialties Geriatric Neurology Written Examination Content Outline
United Council for Neurologic Subspecialties Geriatric Neurology Written Examination Content Outline REV 3/24/09 The UCNS Geriatric Neurology examination was established to determine the level of competence
More informationCANCER-RELATED BRAIN FOG. Angela Boudreau, RN, MN, CON(C) Odette Cancer Centre, Sunnybrook Health Sciences Centre
CANCER-RELATED BRAIN FOG Angela Boudreau, RN, MN, CON(C) Odette Cancer Centre, Sunnybrook Health Sciences Centre What are we talking about? Research has shown that 1 in 3 people who have had treatment
More informationParkinson s Disease WHERE HAVE WE BEEN, WHERE ARE WE HEADING? CHARLECE HUGHES D.O.
Parkinson s Disease WHERE HAVE WE BEEN, WHERE ARE WE HEADING? CHARLECE HUGHES D.O. Parkinson s Epidemiology AFFECTS 1% OF POPULATION OVER 65 MEAN AGE OF ONSET 65 MEN:WOMEN 1.5:1 IDIOPATHIC:HEREDITARY 90:10
More informationDementia ALI ABBAS ASGHAR-ALI, MD STAFF PSYCHIATRIST MICHAEL E. DEBAKEY VA MEDICAL CENTER ASSOCIATE PROFESSOR BAYLOR COLLEGE OF MEDICINE
Dementia ALI ABBAS ASGHAR-ALI, MD STAFF PSYCHIATRIST MICHAEL E. DEBAKEY VA MEDICAL CENTER ASSOCIATE PROFESSOR BAYLOR COLLEGE OF MEDICINE Objectives At the conclusion of the session, participants will be
More informationMental Health: Subjective evaluation of overall quality of life (QOL) Happiness, life satisfaction, morale, trait effect, etc. Quality of Life (QOL)
Mental Health: Subjective evaluation of overall quality of life (QOL) Happiness, life satisfaction, morale, trait effect, etc. Quality of Life (QOL) Multidimensional concept Includes: Physical health Cognitive
More informationPD ExpertBriefing: Fatigue, Sleep Disorders and Parkinson's Disease. Presented By:
PD ExpertBriefing: Fatigue, Sleep Disorders and Parkinson's Disease Presented By: Joseph H. Friedman, M.D. Movement Disorders Program Butler Hospital Department of Neurology Alpert Medical School of Brown
More informationApathy, fatigue and quality of life in patients with Parkinson's disease Skorvanek, Matej
University of Groningen Apathy, fatigue and quality of life in patients with Parkinson's disease Skorvanek, Matej IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's PDF) if
More informationThe following are Alison Williams' notes on these topics, augmented by her comments on two lectures on the same themes. For the original lectures go to: https://events.qwikcast.tv/public/qwikcast/qwikcastevent?eventkey=1a1dbe73-e2f2-4945-9470-143f3f641805
More informationDepression major depressive disorder. Some terms: Major Depressive Disorder: Major Depressive Disorder:
Depression major depressive disorder Oldest recognized disorder: melancholia It is a positive and active anguish, a sort of psychical neuralgia wholly unknown to normal life. - William James "I am now
More informationMotivation & Emotion. Outline Intrinsic & extrinsic motivation. Intrinsic-extrinsic motivations & goal-setting. Intrinsic motivation
Motivation & Emotion Intrinsic-extrinsic motivations & goal-setting Dr James Neill Centre for Applied Psychology University of Canberra 2014 Image source 1 Outline Intrinsic & extrinsic motivation Intrinsic
More informationNeurocognitive Impairments in HIV: Natural History, Impacts on Everyday Functioning and Promising Interventions
Neurocognitive Impairments in HIV: Natural History, Impacts on Everyday Functioning and Promising Interventions Sean B. Rourke, Ph.D. Scientist and Neuropsychologist, St. Michael s Hospital Director, CIHR
More informationManaging Pain. in Marfan Syndrome. Traci J. Speed, MD PhD Assistant Professor, Department of Psychiatry and Behavioral Sciences
Managing Pain in Marfan Syndrome Traci J. Speed, MD PhD Assistant Professor, Department of Psychiatry and Behavioral Sciences No financial disclosures Objectives Define pain Discuss the role of comorbid
More information